| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780860 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
Overall, our results show that non-vulvar MOGS are aggressive tumors with poor long-term clinical outcome and indicate that few targeted therapeutic options are currently available to patients with MOGS.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Aaron M. Udager, Nora K. Frisch, Linda J. Hong, Marina Stasenko, Carolyn M. Johnston, J. Rebecca Liu, May P. Chan, Paul W. Harms, Douglas R. Fullen, Amy Orsini, Dafydd G. Thomas, Lori Lowe, Rajiv M. Patel,